To include your compound in the COVID-19 Resource Center, submit it here.

Natrecor nesiritide: Phase III

In SCIO's 498-patient U.S. Phase III Vasodilation in the Management of Acute CHF (VMAC) study, Natrecor gave a significant improvement in pulmonary capillary wedge pressure (PCWP)

Read the full 267 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE